ESR1 and breast cancer: The results of the present study show that the expression levels of miR-342 were markedly higher in the ERα-positive breast cancer tumors than in the ERα-negative tumors and that the levels of miR-342 gradually increased as ERα mRNA expression increased, suggesting that miR-342 is a key factor for the regulation of ERα expression in the development and progression of human breast cancer.